Literature DB >> 29893478

Remodelling of human bone on the chorioallantoic membrane of the chicken egg: De novo bone formation and resorption.

Inés Moreno-Jiménez1, Stuart A Lanham1, Janos M Kanczler1, Gry Hulsart-Billstrom1, Nicholas D Evans1, Richard O C Oreffo1.   

Abstract

Traditionally used as an angiogenic assay, the chorioallantoic membrane (CAM) assay of the chick embryo offers significant potential as an in vivo model for xenograft organ culture. Viable human bone can be cultivated on the CAM and increases in bone volume are evident; however, it remains unclear by what mechanism this change occurs and whether this reflects the physiological process of bone remodelling. In this study we tested the hypothesis that CAM-induced bone remodelling is a consequence of host and graft mediated processes. Bone cylinders harvested from femoral heads post surgery were placed on the CAM of green fluorescent protein (GFP)-chick embryos for 9 days, followed by micro computed tomography (μCT) and histological analysis. Three-dimensional registration of consecutive μCT-scans showed newly mineralised tissue in CAM-implanted bone cylinders, as well as new osteoid deposition histologically. Immunohistochemistry demonstrated the presence of bone resorption and formation markers (Cathepsin K, SOX9 and RUNX2) co-localising with GFP staining, expressed by avian cells only. To investigate the role of the human cells in the process of bone formation, decellularised bone cylinders were implanted on the CAM and comparable increases in bone volume were observed, indicating that avian cells were responsible for the bone mineralisation process. Finally, CAM-implantation of acellular collagen sponges, containing bone morphogenetic protein 2, resulted in the deposition of extracellular matrix and tissue mineralisation. These studies indicate that the CAM can respond to osteogenic stimuli and support formation or resorption of implanted human bone, providing a humanised CAM model for regenerative medicine research and a novel short-term in vivo model for tissue engineering and biomaterial testing.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  3D registration, in vivo; BMP2, preclinical model; chorioallantoic membrane (CAM assay); human bone; micro computed tomography (μCT); tissue engineering

Mesh:

Year:  2018        PMID: 29893478     DOI: 10.1002/term.2711

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  6 in total

1.  Human and mouse bones physiologically integrate in a humanized mouse model while maintaining species-specific ultrastructure.

Authors:  I Moreno-Jiménez; A Cipitria; A Sánchez-Herrero; A F van Tol; A Roschger; C A Lahr; J A McGovern; D W Hutmacher; P Fratzl
Journal:  Sci Adv       Date:  2020-10-28       Impact factor: 14.136

2.  Does Platelet-Rich Fibrin Enhance the Early Angiogenetic Potential of Different Bone Substitute Materials? An In Vitro and In Vivo Analysis.

Authors:  Sebastian Blatt; Daniel G E Thiem; Andreas Pabst; Bilal Al-Nawas; Peer W Kämmerer
Journal:  Biomedicines       Date:  2021-01-10

Review 3.  Ex vivo Bone Models and Their Potential in Preclinical Evaluation.

Authors:  E E A Cramer; K Ito; S Hofmann
Journal:  Curr Osteoporos Rep       Date:  2021-01-11       Impact factor: 5.096

Review 4.  The Role of Pre-Clinical 3-Dimensional Models of Osteosarcoma.

Authors:  Hannah L Smith; Stephen A Beers; Juliet C Gray; Janos M Kanczler
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

Review 5.  Evolving applications of the egg: chorioallantoic membrane assay and ex vivo organotypic culture of materials for bone tissue engineering.

Authors:  Karen M Marshall; Janos M Kanczler; Richard Oc Oreffo
Journal:  J Tissue Eng       Date:  2020-10-20       Impact factor: 7.813

6.  3D-microtissue derived secretome as a cell-free approach for enhanced mineralization of scaffolds in the chorioallantoic membrane model.

Authors:  Lukas Otto; Petra Wolint; Annina Bopp; Anna Woloszyk; Anton S Becker; Andreas Boss; Roland Böni; Maurizio Calcagni; Pietro Giovanoli; Simon P Hoerstrup; Maximilian Y Emmert; Johanna Buschmann
Journal:  Sci Rep       Date:  2021-03-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.